228 related articles for article (PubMed ID: 25247273)
1. Systemic treatment with fumaric acid esters in six paediatric patients with psoriasis in a psoriasis centre.
Steinz K; Gerdes S; Domm S; Mrowietz U
Dermatology; 2014; 229(3):199-204. PubMed ID: 25247273
[TBL] [Abstract][Full Text] [Related]
2. Fumaderm® in daily practice for psoriasis: dosing, efficacy and quality of life.
Walker F; Adamczyk A; Kellerer C; Belge K; Brück J; Berner T; Merten K; Núnez Gómez N; Neureither M; Röcken M; Ghoreschi K;
Br J Dermatol; 2014 Nov; 171(5):1197-205. PubMed ID: 24813676
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness and safety of fumaric acid esters in children with psoriasis: a retrospective analysis of 14 patients from The Netherlands.
Balak DM; Oostveen AM; Bousema MT; Venema AW; Arnold WP; Seyger MM; Thio HB
Br J Dermatol; 2013 Jun; 168(6):1343-7. PubMed ID: 23738641
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of fumaric acid esters in the long-term treatment of psoriasis--a retrospective study (FUTURE).
Reich K; Thaci D; Mrowietz U; Kamps A; Neureither M; Luger T
J Dtsch Dermatol Ges; 2009 Jul; 7(7):603-11. PubMed ID: 19459898
[TBL] [Abstract][Full Text] [Related]
5. Retrospective data collection of psoriasis treatment with fumaric acid esters in children and adolescents in Germany (KIDS FUTURE study).
Reich K; Hartl C; Gambichler T; Zschocke I
J Dtsch Dermatol Ges; 2016 Jan; 14(1):50-8. PubMed ID: 26713639
[TBL] [Abstract][Full Text] [Related]
6. Treatment of severe, recalcitrant, chronic plaque psoriasis with fumaric acid esters: a prospective study.
Wain EM; Darling MI; Pleass RD; Barker JN; Smith CH
Br J Dermatol; 2010 Feb; 162(2):427-34. PubMed ID: 19519838
[TBL] [Abstract][Full Text] [Related]
7. Fumaric acid esters in severe psoriasis, including experience of use in combination with other systemic modalities.
Balasubramaniam P; Stevenson O; Berth-Jones J
Br J Dermatol; 2004 Apr; 150(4):741-6. PubMed ID: 15099371
[TBL] [Abstract][Full Text] [Related]
8. Regulated genes in psoriatic skin during treatment with fumaric acid esters.
Onderdijk AJ; Balak DM; Baerveldt EM; Florencia EF; Kant M; Laman JD; van IJcken WF; Racz E; de Ridder D; Thio HB; Prens EP
Br J Dermatol; 2014 Oct; 171(4):732-41. PubMed ID: 24852654
[TBL] [Abstract][Full Text] [Related]
9. Renal dysfunction in patients taking fumaric acid esters - a retrospective cross-sectional study.
Menzies S; Ismail N; Abdalla A; Collins P; Kirby B; Holian J; Lally A
J Eur Acad Dermatol Venereol; 2017 Apr; 31(4):686-691. PubMed ID: 27790753
[TBL] [Abstract][Full Text] [Related]
10. Treatment of psoriasis with fumaric acid esters (Fumaderm).
Mrowietz U; Altmeyer P; Bieber T; Röcken M; Schopf RE; Sterry W
J Dtsch Dermatol Ges; 2007 Aug; 5(8):716-7. PubMed ID: 17659047
[No Abstract] [Full Text] [Related]
11. Proteinuria with fumaric acid ester treatment for psoriasis.
Ogilvie S; Lewis Jones S; Dawe R; Foerster J
Clin Exp Dermatol; 2011 Aug; 36(6):632-4. PubMed ID: 21771009
[TBL] [Abstract][Full Text] [Related]
12. [New information about fumaric acid esters (Fumaderm): results of a workshop of experts].
Mrowietz U; Adamczyk A; Augustin M; Boehncke WH; Bonnekoh B; Gambichler T; Hengge U; Lippert U; Ludwig RJ; Luger T; Merk HF; Norgauer J; Philipp S; Reich K; Röcken M; Rostami-Yazdi M; Schön MP; Scola N; Sticherling M; Thaci D; Viehweg A; Wallbrecht K; Wozel G; Zouboulis CC; Neureither M
J Dtsch Dermatol Ges; 2011 Sep; 9 Suppl 4():1-13. PubMed ID: 21899710
[No Abstract] [Full Text] [Related]
13. Disseminated granuloma annulare--treatment with fumaric acid esters.
Eberlein-König B; Mempel M; Stahlecker J; Forer I; Ring J; Abeck D
Dermatology; 2005; 210(3):223-6. PubMed ID: 15785051
[TBL] [Abstract][Full Text] [Related]
14. Long-term real-life safety profile and effectiveness of fumaric acid esters in psoriasis patients: a single-centre, retrospective, observational study.
Dickel H; Bruckner T; Altmeyer P
J Eur Acad Dermatol Venereol; 2018 Oct; 32(10):1710-1727. PubMed ID: 29705996
[TBL] [Abstract][Full Text] [Related]
15. Drug survival of fumaric acid esters for psoriasis: a retrospective study.
Ismail N; Collins P; Rogers S; Kirby B; Lally A
Br J Dermatol; 2014 Aug; 171(2):397-402. PubMed ID: 24471408
[TBL] [Abstract][Full Text] [Related]
16. Fumaric acid esters for the treatment of psoriasis in Germany: characterising patients in routine care.
Mrowietz U; Sorbe C; Reich K; Von Kiedrowski R; Weckbecker J; Radtke MA; Rustenbach SJ; Augustin M
Eur J Dermatol; 2020 Feb; 30(1):41-48. PubMed ID: 32250255
[TBL] [Abstract][Full Text] [Related]
17. Methotrexate vs. fumaric acid esters in moderate-to-severe chronic plaque psoriasis: data registry report on the efficacy under daily life conditions.
Inzinger M; Weger W; Heschl B; Salmhofer W; Quehenberger F; Wolf P
J Eur Acad Dermatol Venereol; 2013 Jul; 27(7):861-6. PubMed ID: 22672248
[TBL] [Abstract][Full Text] [Related]
18. Fumaric acid esters in combination with a 6-week course of narrowband ultraviolet B provides an accelerated response compared with fumaric acid esters monotherapy in patients with moderate-to-severe plaque psoriasis: a randomized prospective clinical study.
Tzaneva S; Geroldinger A; Trattner H; Tanew A
Br J Dermatol; 2018 Mar; 178(3):682-688. PubMed ID: 29114862
[TBL] [Abstract][Full Text] [Related]
19. Addition of an oral histamine antagonist to reduce adverse events associated with fumaric acid esters in the treatment of psoriasis: a randomized double-blind placebo-controlled trial.
Balak DM; Fallah-Arani S; Venema CM; Neumann HA; Thio HB
Br J Dermatol; 2015 Mar; 172(3):754-9. PubMed ID: 25041291
[TBL] [Abstract][Full Text] [Related]
20. Fumaric acid esters in the management of severe psoriasis.
Brewer L; Rogers S
Clin Exp Dermatol; 2007 May; 32(3):246-9. PubMed ID: 17362235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]